Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Why is Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 20.80% and Operating profit at 37.40% over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 367.92 MM
NET SALES(9M) At CNY 965.1 MM has Grown at 17.89%
ROCE(HY) Highest at 18.73%

With ROE of 16.38%, it has a attractive valuation with a 4.75 Price to Book Value

Over the past year, while the stock has generated a return of 73.77%, its profits have risen by 35%

Market Beating performance in long term as well as near term

Along with generating 73.77% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. should be less than 10%
Overall Portfolio exposure to FMCG should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

-5.27%

0.13

52.79%

China Shanghai Composite

20.36%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.87%

EBIT Growth (5y)

37.40%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.58

Tax Ratio

10.65%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

14.36%

ROE (avg)

13.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.43

EV to EBIT

27.06

EV to EBITDA

22.24

EV to Capital Employed

6.03

EV to Sales

7.72

PEG Ratio

3.60

Dividend Yield

ROCE (Latest)

22.28%

ROE (Latest)

17.43%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company

NET SALES(HY)

At CNY 802.77 MM has Grown at 25.41%

ROCE(HY)

Highest at 21.22%

PRE-TAX PROFIT(Q)

Highest at CNY 142.3 MM

NET PROFIT(Q)

Highest at CNY 120.66 MM

RAW MATERIAL COST(Y)

Fallen by -16.6% (YoY

EPS(Q)

Highest at CNY 0.29

-11What is not working for the Company

INTEREST(HY)

At CNY 3.76 MM has Grown at 135.05%

DEBT-EQUITY RATIO (HY)

Highest at -9.37 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.25 times

OPERATING PROFIT MARGIN(Q)

Lowest at 36.17 %

Here's what is working for Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Pre-Tax Profit

Highest at CNY 142.3 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 120.66 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 802.77 MM has Grown at 25.41%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

EPS

Highest at CNY 0.29

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -16.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Interest

At CNY 3.76 MM has Grown at 135.05%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit Margin

Lowest at 36.17 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debt-Equity Ratio

Highest at -9.37 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 3.25 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio